Bill Ackman And Valeant Pharma Are Reportedly Making A Bid On Botox-Maker Allergan

Shares of pharmaceutical company Allergan are exploding in the after hours session.

The Wall Street Journal reports that activist investor Bill Ackman of Pershing Square is partnering with Valeant Pharmaceuticals to pursue a takeover of Allergan.

Ackman has built a 10% stake in the company worth $US4 billion, according to the report.

Allergan makes Botox and eye care products.

Allergan’s is up more than 19% in the after-hours session. Meanwhile, Valeant’s stock was last up about 9%.

Here’s Allergan’s trading activity today:

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at